Tag: deruxtecan
AstraZeneca India launches Trastuzumab deruxtecan for HER-2 positive metastatic breast cancer...
Developed in collaboration with Daiichi Sankyo, Trastuzumab deruxtecan is a specifically engineered HER2-directed antibody drug conjugate